Showing results (1-10 of 770) with videos related to
Sort By:
Pageof 77
Current Drug Targets|October 2, 2015
B1-Metallo-β-Lactamases: Where Do We Stand?Maria F Mojica, Robert A Bonomo, Walter FastCurrent Opinion in Infectious Diseases|October 17, 2023
Treatment approaches for severe Stenotrophomonas maltophilia infectionsMaria F Mojica, Robert A Bonomo, David van DuinThe Lancet. Infectious Diseases|July 11, 2021
The urgent need for metallo-β-lactamase inhibitors: an unattended global threatMaria F Mojica, Maria-Agustina Rossi, Alejandro J Vila, et al.The Lancet. Microbe|May 11, 2026
Treatment strategies for imipenemase-producing Gram-negative infections: lessons from JapanDaisuke Ono, Sohei Harada, Yoshikazu Ishii, et al.Trends in Pharmacological Sciences|April 23, 2018
The Continuing Challenge of Metallo-β-Lactamase Inhibition: Mechanism MattersLin-Cheng Ju, Zishuo Cheng, Walter Fast, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 8, 2025
How do I manage a patient with Stenotrophomonas maltophilia infection?Roberta Monardo, Maria F Mojica, Marco Ripa, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|December 29, 2023
Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration systemLeila S Hojat, Brigid M Wilson, Federico Perez, et al.Microbiology Spectrum|December 23, 2025
Exploring the activity of a novel orally bioavailable β-lactam-β-lactamase inhibitor combination, ceftibuten-ledaborbactam, against Enterobacterales-carrying blaOXA-48Maria F Mojica, Elise T Zeiser, Scott A Becka, et al.Journal of Chemical Information and Modeling|April 30, 2024
Deciphering the Coevolutionary Dynamics of L2 β-Lactamases via Deep LearningYu Zhu, Jing Gu, Zhuoran Zhao, et al.Pageof 77